Transform treatment by harnessing the power of T cells to create a new generation of targeted cancer immunotherapies and infectious disease vaccines.LEARN MORE
Our T cell activating platforms train the immune system to unleash a powerful targeted T cell attack and could dramatically improve treatment and outcomes for patients with cancer.LEARN MORE
PDS Biotech was established with the goal of harnessing the power of T cells to address some of the most devastating illnesses of our time. While many companies have tried to leverage the body’s own immune system to induce a powerful T cell response, most have been unsuccessful in inducing the right type and quantity of potent tumor-infiltrating T cells to execute a targeted attack. Scientists at PDS Biotech designed proprietary cationic, lipid-based nanoparticle platform technologies to overcome these limitations.